The WACC of Constellation Pharmaceuticals Inc (CNST) is 4.6%.
Range | Selected | |
Cost of equity | 4.70% - 6.30% | 5.50% |
Tax rate | 27.00% - 27.00% | 27.00% |
Cost of debt | 5.00% - 5.00% | 5.00% |
WACC | 4.2% - 5.0% | 4.6% |
Category | Low | High |
Long-term bond rate | 3.2% | 3.7% |
Equity market risk premium | 4.2% | 5.2% |
Adjusted beta | 0.36 | 0.4 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 4.70% | 6.30% |
Tax rate | 27.00% | 27.00% |
Debt/Equity ratio | 1 | 1 |
Cost of debt | 5.00% | 5.00% |
After-tax WACC | 4.2% | 5.0% |
Selected WACC | 4.6% | |